Drugs & Targets Lenvima + Keytruda get Breakthrough designation for endometrial carcinoma August 03, 2018Vol.44 No.31
Drugs & Targets Pfizer receives European approval for biosimilar trastuzumab August 03, 2018Vol.44 No.31
Clinical Roundup Study identifies genes associated with risk for triple negative breast cancer August 03, 2018Vol.44 No.31
Clinical Roundup Lung cancer mortality rates in women to increase worldwide by over 40 percent by 2030 August 03, 2018Vol.44 No.31
Clinical Roundup Tumor Treating Fields + paclitaxel may improve survival in ovarian cancer August 03, 2018Vol.44 No.31
In Brief University of Minnesota Masonic Cancer Center receives “outstanding” rating August 03, 2018Vol.44 No.31
In Brief Dominic Seraphin named VP of Strategic Alliances & Network at Moffitt August 03, 2018Vol.44 No.31
House committee defoliates NIH funding for WHO program that declares weedkiller Roundup a carcinogen August 03, 2018Vol.44 No.31By Jordan Williams
Conversation with The Cancer Letter AACR’s Sweeney: Adoption of data standards necessary for advancing real-world evidence in precision oncology August 03, 2018Vol.44 No.31By Matthew Bin Han Ong
